FMP
MediWound Ltd.
MDWD
NASDAQ
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
16.99 USD
-0.45 (-2.65%)
About
ceo
Dr. Lior Rosenberg M.D.
sector
Healthcare
industry
Biotechnology
website
https://www.mediwound.com
exchange
NASDAQ
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
CIK
0001593984
ISIN
IL0011316309
CUSIP
M68830104
Address
42 Hayarkon Street
Phone
972 7 797 14100
Country
IL
Employee
100
IPO Date
Mar 20, 2014
Summary
CIK
0001593984
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
M68830104
ISIN
IL0011316309
Country
IL
Price
16.99
Beta
0.93
Volume Avg.
72.39k
Market Cap
161.26M
Shares
-
52-Week
7.1-18.75
DCF
-5.8
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-22.65
P/B
-
Website
https://www.mediwound.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MDWD News
It looks like there's no news available.
